Robert S Fujinami Selected Research

1H-indole-3-carbaldehyde quinolin-8-yl-hydrazone

7/2014	Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
3/2012	Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert S Fujinami Research Topics

Disease

27	Infections 09/2019 - 05/2002
16	Seizures (Absence Seizure) 09/2019 - 06/2008
16	Virus Diseases (Viral Diseases) 09/2019 - 04/2002
14	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 04/2003
14	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 05/2002
12	Multiple Sclerosis 07/2014 - 05/2002
9	Inflammation (Inflammations) 03/2019 - 01/2007
6	Epilepsy (Aura) 01/2019 - 12/2010
6	Autistic Disorder (Autism) 08/2010 - 02/2005
4	Autoimmune Diseases (Autoimmune Disease) 05/2014 - 08/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 11/2003
3	Central Nervous System Diseases (CNS Diseases) 07/2016 - 09/2010
3	Tourette Syndrome (Tourette's Syndrome) 02/2008 - 06/2007
2	Picornaviridae Infections 01/2021 - 01/2016
2	Central Nervous System Infections (Central Nervous System Infection) 09/2019 - 03/2017
2	Drug Resistant Epilepsy 09/2019 - 03/2019
2	Neuroinflammatory Diseases 07/2019 - 01/2018
2	Paralysis (Palsy) 01/2019 - 01/2019
2	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 02/2013
2	Gliosis 10/2011 - 03/2010
2	Progressive Multifocal Leukoencephalopathy 09/2010 - 01/2007
2	Measles 06/2007 - 02/2005
2	Mumps 06/2007 - 02/2005
2	Rubella (German Measles) 06/2007 - 02/2005
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	T-Cell Leukemia (Leukemia, T Cell) 03/2013
1	Genomic Instability 03/2013
1	Human Influenza (Influenza) 07/2012
1	Viral Encephalitis 10/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2010
1	Chorea (Rheumatic Chorea) 08/2010

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2019 - 02/2004
9	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2010
8	Proteins (Proteins, Gene)FDA Link 03/2017 - 05/2005
8	Peptides (Polypeptides)IBA 06/2015 - 03/2005
6	CytokinesIBA 01/2019 - 02/2006
6	AntibodiesIBA 08/2010 - 04/2002
5	Messenger RNA (mRNA)IBA 03/2017 - 02/2004
5	Myelin-Oligodendrocyte GlycoproteinIBA 02/2007 - 03/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 03/2010
4	Myelin Proteolipid ProteinIBA 07/2014 - 01/2007
4	Antiviral Agents (Antivirals)IBA 05/2014 - 03/2006
4	DNA (Deoxyribonucleic Acid)IBA 04/2012 - 12/2005
4	EnzymesIBA 02/2008 - 05/2006
3	InterleukinsIBA 01/2019 - 02/2006
3	Biological ProductsIBA 03/2013 - 02/2005
3	Minocycline (Cyclops)FDA LinkGeneric 02/2013 - 07/2011
3	Capsid Proteins (Capsid Protein)IBA 04/2012 - 03/2006
3	Viral AntigensIBA 10/2008 - 12/2002
3	AutoantibodiesIBA 08/2008 - 02/2008
3	ImmunosorbentsIBA 02/2008 - 06/2007
2	PLX5622IBA 01/2021 - 01/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 03/2019 - 01/2016
2	Glutamate Receptors (Glutamate Receptor)IBA 03/2017 - 01/2016
2	Complement System Proteins (Complement)IBA 01/2017 - 07/2010
2	Pharmaceutical PreparationsIBA 01/2016 - 03/2013
2	1H-indole-3-carbaldehyde quinolin-8-yl-hydrazoneIBA 07/2014 - 03/2012
2	Interleukin-17 (Interleukin 17)IBA 12/2012 - 07/2012
2	Freund's AdjuvantIBA 12/2012 - 02/2006
2	EpitopesIBA 01/2006 - 05/2002
2	Immunoglobulins (Immunoglobulin)IBA 03/2005 - 07/2003
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	CannabidiolIBA 09/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2019
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 07/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Immunotoxins (Immunotoxin)IBA 01/2019
1	N- cyclobutyl- 6- ((3- fluorophenyl)ethynyl)nicotinamideIBA 01/2019
1	Chemokine CXCL1IBA 01/2018
1	Type II Tumor Necrosis Factor ReceptorsIBA 03/2017
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2017
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2017
1	Soybean Proteins (Soy Protein)IBA 07/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	N-Methylaspartate (NMDA)IBA 01/2016
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2016
1	Ionotropic Glutamate ReceptorsIBA 01/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2016
1	GYKI 52466IBA 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Insulin-Like PeptidesIBA 01/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2013
1	Immunomodulating AgentsIBA 03/2013
1	wogoninIBA 02/2013
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 12/2012
1	Interleukin-22 (IL-22)IBA 07/2012
1	MitogensIBA 07/2012
1	Complement C3 (C3 Complement)IBA 11/2011
1	LigandsIBA 07/2011
1	ChemokinesIBA 07/2011
1	VaccinesIBA 04/2011
1	cobra venom factorIBA 07/2010
1	Viral RNAIBA 03/2010
1	Interleukin-1 (Interleukin 1)IBA 03/2010
1	Interleukin-4 (Interleukin 4)IBA 01/2009
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2009

Therapy/Procedure

8	Therapeutics 09/2019 - 03/2006
1	Drug Therapy (Chemotherapy) 03/2017